Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and HHS. The company now faces a lawsuit from Novo Nordisk for patent ...
NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health (HIMS.N), opens new tab on Thursday began offering a much cheaper $49 compounded version of Novo Nordisk's (NOVOb.CO), opens ...
Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January. By Jan. 23 — less than three weeks after it became available — ...
The old term was “compliance”; today, the preferred label is “adherence”. Whatever you call it, getting patients to keep taking their meds is a big deal. First, it benefits the patient: non-adherence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results